Cyclosporine and experimental skin allografts: II. Indefinite survival and development of specific immunologic unresponsiveness

Edward Towpik, Jerzy W. Kupiec-Weglinski, Tobin M. Schneider, Douglas Tyler, Winfried Padberg, Dorian Araneda, Nicholas L. Tilney

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Immunological unresponsiveness toward skin allografts was studied in cyclosporine (CsA)-treated rats. BN skin grafts survive about 22 days and about 34 days in LEW hosts following 7 or 14 days of daily CsA treatment (15 mg/kg/day), respectively; in unmodified hosts grafts are rejected by 9 days. Indefinite (>100 days) survival can, however, be produced by administering maintenance 15 mg/kg CsA every fourth day, following an initial course of the agent for 14 days. Early signs of graft rejection (hair loss, localized epidermal breakdown, and ulcerations) occurring in some animals were reversed by a CsA “pulse” (15 mg/kg/day) for 7 days, reduced gradually to the maintenance dose. CsA was equally effective when started as late as 4 days after grafting, but ineffectual when started after day 4. Once BN grafts were rejected, the agent could not prevent second-set rejection of donor-specific grafts, but significantly prolonged the survival of third-party (WF) skins. Survival of original BN grafts was unchanged by the placement of second BN grafts during both the inductive and maintenance phases; these second grafts survived as long as the original grafts. In contrast, secondary third-party (WF) grafts were promptly rejected; their destruction did not influence survival of the original grafts. Thus, idefinite survival of rat skin allografts is feasible with low maintenance doses of CsA. Graft rejection at later stages can be reversed by resuming daily therapy. Host unresponsiveness is stable and specific both during the early inductive and later maintenance phases.

Original languageEnglish (US)
Pages (from-to)714-718
Number of pages5
Issue number6
StatePublished - Dec 1985
Externally publishedYes

ASJC Scopus subject areas

  • Transplantation


Dive into the research topics of 'Cyclosporine and experimental skin allografts: II. Indefinite survival and development of specific immunologic unresponsiveness'. Together they form a unique fingerprint.

Cite this